Key takeaways: GLP-1 medications are primarily used for weight loss, but are increasingly being explored in relation to PCOS and perimenopause Early evidence (mainly in women with obesity and PCOS) suggests GLP-1s may improve insulin resistance and support more regular menstrual cycles and ovulation There is currently limited research on how GLP-1 medications affect periods, fertility, PMS, or menopause symptoms in the wider population Period tracking apps like Clue may help users monitor cycle and symptom changes while using GLP-1 medications 1
Figure 1OA shows co-localization of TO 14 (VEGFR2 antibody) and F4/80 (macrophage marker) staining on tumor sections from control treated or 2C3 treated animals
Exclusion criteria included recent cardiovascular events and severe renal impairment (estimated glomerular filtration rate 15 mL/min/1.73 m 2 )
placebo suggest patients enjoy at least as good, if not better, outcomes from the combination of therapies
An Integrative Perspective From an integrative perspective, lets remember that GLP-1 medications are just one tool, and they do come with side effects and important considerations